138 related articles for article (PubMed ID: 28266313)
1. Development of a plasminogen activator inhibitor (PAI-1) assay and comparison of plasma PAI-1 activity in hyperlipidemic/dyslipidemic dogs with either hyperadrenocorticism or diabetes mellitus, and healthy dogs.
Wong CJ; Koch M; Behling-Kelly EL
Res Vet Sci; 2017 Apr; 111():1-8. PubMed ID: 28266313
[TBL] [Abstract][Full Text] [Related]
2. Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis.
Urano T; Suzuki Y; Iwaki T; Sano H; Honkura N; Castellino FJ
Curr Drug Targets; 2019; 20(16):1695-1701. PubMed ID: 31309890
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs.
Lanevschi A; Kramer JW; Greene SA; Meyers KM
Am J Vet Res; 1996 Aug; 57(8):1124-30. PubMed ID: 8836361
[TBL] [Abstract][Full Text] [Related]
4. Increases in beta-lipoproteins in hyperlipidemic and dyslipidemic dogs are associated with increased erythrocyte osmotic fragility.
Behling-Kelly E; Collins-Cronkright R
Vet Clin Pathol; 2014 Sep; 43(3):405-15. PubMed ID: 24976106
[TBL] [Abstract][Full Text] [Related]
5. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
[TBL] [Abstract][Full Text] [Related]
6. Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis.
Diaz JA; Ballard-Lipka NE; Farris DM; Hawley AE; Wrobleski SK; Myers DD; Henke PK; Lawrence DA; Wakefield TW
J Vasc Surg; 2012 Mar; 55(3):815-22. PubMed ID: 22119245
[TBL] [Abstract][Full Text] [Related]
7. Impact of diabetes-associated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells.
Ren S; Lee H; Hu L; Lu L; Shen GX
J Clin Endocrinol Metab; 2002 Jan; 87(1):286-91. PubMed ID: 11788661
[TBL] [Abstract][Full Text] [Related]
8. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
[TBL] [Abstract][Full Text] [Related]
9. Tissue-type plasminogen activator (tPA) and its inhibitor (PAI-1) in patients treated with continuous ambulatory peritoneal dialysis.
Opatrný K; Opatrná S; Vít L; Opatrný K
Am J Nephrol; 1998; 18(3):186-92. PubMed ID: 9627033
[TBL] [Abstract][Full Text] [Related]
10. Effects of astaxanthin on blood coagulation, fibrinolysis and platelet aggregation in hyperlipidemic rats.
Deng ZY; Shan WG; Wang SF; Hu MM; Chen Y
Pharm Biol; 2017 Dec; 55(1):663-672. PubMed ID: 27951728
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolytic activity in Chinese patients with diabetes or hyperlipidemia in comparison with healthy controls.
Ho CH; Jap TS
Thromb Haemost; 1991 Jan; 65(1):3-6. PubMed ID: 1902595
[TBL] [Abstract][Full Text] [Related]
12. Novel distribution pattern of fibrinolytic components in rabbit tissues extract: a preliminary study.
Lu XG; Wu XG; Xu XH; Gong XB; Zhou X; Xu GB; Zhu L; Zhao XY
J Zhejiang Univ Sci B; 2007 Aug; 8(8):570-4. PubMed ID: 17657859
[TBL] [Abstract][Full Text] [Related]
13. Acute psychological stress decreases plasma tissue plasminogen activator (tPA) and tissue plasminogen activator/plasminogen activator inhibitor-1 (tPA/PAI-1) complexes in cardiac patients.
Hevey D; McGee HM; Fitzgerald D; Horgan JH
Eur J Appl Physiol; 2000 Nov; 83(4 -5):344-8. PubMed ID: 11138573
[TBL] [Abstract][Full Text] [Related]
14. Inheritance conjointly contributing to fibrinolysis and hyperlipidemia.
Glueck CJ; Glueck HI; Tracy T; Speirs J; Stroop D
Metabolism; 1993 Nov; 42(11):1410-9. PubMed ID: 8231835
[TBL] [Abstract][Full Text] [Related]
15. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
16. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
Pinsky DJ; Liao H; Lawson CA; Yan SF; Chen J; Carmeliet P; Loskutoff DJ; Stern DM
J Clin Invest; 1998 Sep; 102(5):919-28. PubMed ID: 9727060
[TBL] [Abstract][Full Text] [Related]
17. Markedly impaired fibrinolytic balance contributes to cardiovascular risk in adults with growth hormone deficiency.
Devin JK; Blevins LS; Verity DK; Chen Q; Bloodworth JR; Covington J; Vaughan DE
J Clin Endocrinol Metab; 2007 Sep; 92(9):3633-9. PubMed ID: 17579195
[TBL] [Abstract][Full Text] [Related]
18. Platelet function and fibrinolytic activity in patients with bronchial asthma.
Tutluoglu B; Gurel CB; Ozdas SB; Musellim B; Erturan S; Anakkaya AN; Kilinc G; Ulutin T
Clin Appl Thromb Hemost; 2005 Jan; 11(1):77-81. PubMed ID: 15678276
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of pulsatile and nonpulsatile flow on plasma fibrinolytic balance in pediatric patients undergoing cardiopulmonary bypass.
Aĝirbaşli MA; Song J; Lei F; Wang S; Kunselman AR; Clark JB; Myers JL; Ündar A
Artif Organs; 2014 Jan; 38(1):28-33. PubMed ID: 24237252
[TBL] [Abstract][Full Text] [Related]
20. Platelets retain high levels of active plasminogen activator inhibitor 1.
Brogren H; Wallmark K; Deinum J; Karlsson L; Jern S
PLoS One; 2011; 6(11):e26762. PubMed ID: 22069469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
